课题基金 / 基金详情

Discovery and Development of Small Molecule Toxin Antagonists to Treat C. difficile-Associated Disease

Discovery and Development of Small Molecule Toxin Antagonists to Treat C. difficile-Associated Disease
治疗艰难梭菌相关疾病的小分子毒素拮抗剂的发现和开发
批准号:
266523
负责人:
Melnyk Roman
金额:
$36.41万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-09-01 至 2017-09-01

项目摘要

项目成果

Melnyk Roman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the past decade, there have been several outbreaks of Clostridium difficile ("C.diff") in hospitals across Canada and around the world due to the emergence of more infectious strains of this microbe. These "superbug" strains are troubling because they
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
13th International Conference on Molecular Biology and Pathogenesis of Clostridia (Clostpath)
  • 批准号:
    480581
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $1.46万
  • 财政年份:
    2023
  • 负责人:
    Melnyk Roman
  • 依托单位:
Development of a tumour-targeted RAS-specific protease for pancreatic cancer therapy
  • 批准号:
    434733
  • 项目类别:
    Operating Grants
  • 资助金额:
    $64.09万
  • 财政年份:
    2020
  • 负责人:
    Melnyk Roman
  • 依托单位:
Elucidating a new role for bile acids in protecting against C. difficile toxin pathogenesis: Implications for therapy
Development of a Novel Platform to Treat Neuropathic Lysosomal Storage Diseases
  • 批准号:
    345890
  • 项目类别:
    Operating Grants
  • 资助金额:
    $49.01万
  • 财政年份:
    2016
  • 负责人:
    Melnyk Roman
  • 依托单位:
海外基金